Partnerships

We have applied our machine learning capabilities to build endocrine disruption models for global consumer product companies, and ADME models for a large rare disease company. We work with CROs-modeling in vivo animal data, make predictions with target models and predict ADME data to advance their internal drug discovery efforts. We have red-teaming capabilities for testing new AI technologies.

If your company is interested in leveraging our technologies, drug discovery capabilities or licensing our software or molecules then please connect with us and discuss how we could partner.